Monsanto Bets on Next Phase of High-Tech Crops, but It’s Not Alone – Fox Business
|
Monsanto Bets on Next Phase of High-Tech Crops, but It's Not Alone
Fox Business Over the past year, Monsanto has licensed two different Crispr versions, Crispr-Cas and Crispr–Cpf1, as well as the Exzact technology and another gene-editing platform developed by TargetGene Biotechnologies Ltd. The company has recruited medical and … |
